Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability
NCT02002819
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
levetiracetam
Sponsor
University of Minnesota